AI-generated analysis. Always verify with the original filing.
EDAP TMS S.A. reported fourth quarter and full-year 2025 financial results, with record HIFU revenue of €33.1 million for the full year, up 39% YoY, driven by 69% growth in Focal One system placements and 28% U.S. procedure growth in Q4. The company reiterated 2026 revenue guidance of $72.0-$80.0 million, with HIFU revenue expected at $50.0-$54.0 million, representing 34%-45% YoY growth.
Event Type
Disclosure
Mandatory
Variant
8-K
, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or oth
. Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release dated March 25, 2026 104 Cover Page Interactive Data File-the cover page XBRL tags are embe
| Metric | Value | Basis |
|---|---|---|
| Total Revenue Q4 | $18.90 | GAAP |
| HIFU Revenue Q4 | $11.70 | GAAP |
| Non-Core Revenue Q4 | $7.20 | GAAP |
| Gross Margin Q4 | 42.6% | GAAP |
| Operating Loss Q4 | $-5.20 | GAAP |
| Net Loss Q4 | $-8.20 | GAAP |
| Diluted EPS Q4 | $-0.22 | GAAP |
| Total Revenue FY | $62.40 | GAAP |
| HIFU Revenue FY | $33.10 | GAAP |
| Non-Core Revenue FY | $29.40 | GAAP |
| Gross Profit Margin FY | 42.5% | GAAP |
| Operating Loss FY | $-21.90 | GAAP |
| Net Loss FY | $-25.90 | GAAP |
| Diluted EPS FY | $-0.69 | GAAP |